Irreversible stimulation of hydroosmotic response in toad bladder by photoaffinity labeling with [Phe2,Phe-(p-N3)3]Vasopressin.
The photoreactive analogs of vasopressin, [Phe2,Phe-(p-N3)3]AVP (3a) and [Phe-(p-N3)2]AVP (2a), and the chemically reactive analogs of vasopressin, [Phe2,Phe-(p-NHCOCH2Br)3]AVP (3b) and [Phe-(p-NHCOCH2Br)2]AVP (2c), have been tested in the toad bladder for irreversible stimulation or inhibition of the water permeability response. Analog 3a was found to be an agonist with an ED50 of 4.5 X 10(-7) M and to induce a maximal osmotic water flow across bladders equivalent to 74% of that observed with the parent hormone (AVP). Photolysis of this analog in Ringer's fluid resulted in a decrease in its biological activity, with a half-time of 7 min. However, UV irradiation of the analog in the presence of toad bladders triggered an irreversible increase in the permeability of the bladders to water. Under optimal conditions of irradiation, water permeability remained at about 60% of maximum for more than 3 h after washout of analog 3a. The addition of AVP raised the permeability of these bladders to 100%. Analog 3a did not cause irreversible stimulation without photolysis, nor did this analog induce its characteristic effect when added to the mucosal solution. Compound 2a was found to be a potent antagonist of AVP. This inhibitory action of 2a was readily reversed in both the presence and absence of UV irradiation. Compound 3b was also found to be a reversible inhibitor of AVP. Compound 2c was found to be inactive as agonist or antagonist. These studies suggest that analog 3a binds covalently at or near the toad bladder hydroosmotic receptors, resulting in a persistent increase in permeability to water of the bladder wall.
D000345:Affinity Labels / Q000494:pharmacology*; D000818:Animals; D001127:Arginine Vasopressin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002024:Bufo marinus; D002463:Cell Membrane Permeability / Q000187:drug effects*; D005260:Female; D009995:Osmosis / Q000187:drug effects; D010782:Photolysis; D011956:Receptors, Cell Surface / Q000378:metabolism; D017483:Receptors, Vasopressin; D014466:Ultraviolet Rays; D001743:Urinary Bladder / Q000502:physiology*; D014867:Water / Q000378:metabolism*
D000345:Affinity Labels; D011956:Receptors, Cell Surface; D017483:Receptors, Vasopressin; D014867:Water; D001127:Arginine Vasopressin